ATARI trial: ATR inhibitor in combination with olaparib in gynecological cancers with ARID1A loss or no loss (ENGOT/GYN1/NCRI)

Susana Banerjee; James Stewart; Nuria Porta; Christy Toms; Alexandra Leary; Stephanie Lheureux; Saira Khalique; Jeremy Tai; Ayoma Attygalle; Katherine Vroobel; Christopher J Lord; Rachael Natrajan; Judith Bliss

doi:10.1136/ijgc-2021-002973

Article info

Clinical trial

ATARI trial: ATR inhibitor in combination with olaparib in gynecological cancers with ARID1A loss or no loss (ENGOT/GYN1/NCRI)

Authors

Susana Banerjee Gynaecology Unit, Royal Marsden NHS Foundation Trust, London, UK Division of Clinical Studies, The Institute of Cancer Research, London, UK PubMed articles Google scholar articles
James Stewart Gynaecology Unit, Royal Marsden NHS Foundation Trust, London, UK The CRUK Gene Function Laboratory and Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK PubMed articles Google scholar articles
Nuria Porta Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK PubMed articles Google scholar articles
Christy Toms Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK PubMed articles Google scholar articles
Alexandra Leary Oncology Department, Institut Gustave-Roussy, Villejuif, Île-de-France, France PubMed articles Google scholar articles
Stephanie Lheureux Division of Medical Oncology and Hematology, University Health Network, Princess Margaret Cancer Centre, Toronto, Ontario, Canada PubMed articles Google scholar articles
Saira Khalique Gynaecology Unit, Royal Marsden NHS Foundation Trust, London, UK The CRUK Gene Function Laboratory and Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK PubMed articles Google scholar articles
Jeremy Tai Gynaecology Unit, Royal Marsden NHS Foundation Trust, London, UK PubMed articles Google scholar articles
Ayoma Attygalle Gynaecology Unit, Royal Marsden NHS Foundation Trust, London, UK PubMed articles Google scholar articles
Katherine Vroobel Gynaecology Unit, Royal Marsden NHS Foundation Trust, London, UK PubMed articles Google scholar articles
Christopher J Lord The CRUK Gene Function Laboratory and Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK PubMed articles Google scholar articles
Rachael Natrajan The CRUK Gene Function Laboratory and Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK PubMed articles Google scholar articles
Judith Bliss Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK PubMed articles Google scholar articles

Correspondence to Dr Susana Banerjee, Gynaecology Unit, Royal Marsden NHS Foundation Trust, London, UK; susana.banerjee{at}rmh.nhs.uk

View Full Text

Citation

Banerjee S, Stewart J, Porta N, et al

ATARI trial: ATR inhibitor in combination with olaparib in gynecological cancers with ARID1A loss or no loss (ENGOT/GYN1/NCRI)

International Journal of Gynecologic Cancer 2021;31:1471-1475.

Publication history

Accepted August 12, 2021
First published September 13, 2021.

Online issue publication

November 01, 2021

Article Versions

Previous version (13 September 2021).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password